- Home
- LNTH vs EPR Comparison
LNTH vs EPR Comparison
Compare LNTH & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | EPR |
|---|---|---|
| Founded | 1956 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.4B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | LNTH | EPR |
|---|---|---|
| Price | $67.59 | $54.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $78.00 | $57.06 |
| AVG Volume (30 Days) | ★ 788.1K | 713.8K |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 6.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.39 | 2.29 |
| Revenue | ★ $1,525,933,000.00 | $707,150,000.00 |
| Revenue This Year | $0.01 | $5.20 |
| Revenue Next Year | $0.26 | $2.95 |
| P/E Ratio | $28.21 | ★ $23.71 |
| Revenue Growth | 1.95 | ★ 3.73 |
| 52 Week Low | $47.25 | $41.75 |
| 52 Week High | $111.29 | $61.24 |
Technical Indicators
Market Signals| Indicator | LNTH | EPR |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 60.99 |
| Support Level | $63.37 | $54.51 |
| Resistance Level | $67.92 | $56.03 |
| Average True Range (ATR) | 2.06 | 1.02 |
| MACD | -0.37 | 0.24 |
| Stochastic Oscillator | 58.76 | 67.55 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About EPR EPR Properties
EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.